REGN EPS Estimates
Regeneron Pharmaceuticals, Inc.
$778.36
+$25.24(+3.35%)
59
Overall
80
Value
40
Tech
57
Quality
Market Cap
$80.14B
Volume
878.09K
52W Range
$541.00 - $859.34
Target Price
$861.62
REGN EPS estimates: the consensus estimate for Regeneron Pharmaceuticals, Inc.'s current fiscal year is $47.93 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
REGN EPS Estimates
- EPS estimate, current quarter
- $13.58
- EPS estimate, next quarter
- $15.95
- EPS estimate, current year
- $47.93
- EPS estimate, next year
- $52.91
- EPS growth, 3-year
- +2.06%
| Fiscal year | EPS |
|---|---|
| 2025 | $43.07 |
| 2024 | $40.90 |
| 2023 | $37.05 |
| 2022 | $40.51 |
| 2021 | $76.40 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | REGN | $778.36 | +3.4% | 878.09K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Regeneron Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW